Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.
Almejún MB, Borge M, Colado A, Elías EE, Podaza E, Risnik D, De Brasi CD, Stanganelli C, Slavutsky I, Cabrejo M, Fernández-Grecco H, Bezares RF, Cranco S, Burgos RÁ, Sánchez-Ávalos JC, Oppezzo P, Giordano M, Gamberale R. Almejún MB, et al. Among authors: elias ee. Haematologica. 2017 Jul;102(7):e257-e260. doi: 10.3324/haematol.2017.167353. Epub 2017 Mar 30. Haematologica. 2017. PMID: 28360148 Free PMC article. No abstract available.
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.
Risnik D, Podaza E, Almejún MB, Colado A, Elías EE, Bezares RF, Fernández-Grecco H, Cranco S, Sánchez-Ávalos JC, Borge M, Gamberale R, Giordano M. Risnik D, et al. Among authors: elias ee. Sci Rep. 2017 Nov 16;7(1):15714. doi: 10.1038/s41598-017-15953-x. Sci Rep. 2017. PMID: 29146966 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 31949014
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.
Podaza E, Palacios F, Croci DO, Risnik D, Yan XJ, Almejún MB, Colado A, Elías EE, Borge M, Morande PE, Bezares R, Fernández-Grecco H, Rabinovich GA, Gamberale R, Chiorazzi N, Giordano M. Podaza E, et al. Among authors: elias ee. Haematologica. 2020 Sep 1;105(9):e465-469. doi: 10.3324/haematol.2019.227975. Haematologica. 2020. PMID: 33054065 Free PMC article. No abstract available.
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Colado A, Almejún MB, Podaza E, Risnik D, Stanganelli C, Elías EE, Dos Santos P, Slavutsky I, Fernández Grecco H, Cabrejo M, Bezares RF, Giordano M, Gamberale R, Borge M. Colado A, et al. Among authors: elias ee. Cancer Immunol Immunother. 2017 Apr;66(4):461-473. doi: 10.1007/s00262-016-1946-y. Epub 2016 Dec 23. Cancer Immunol Immunother. 2017. PMID: 28011996 Free PMC article.
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Elías EE, Almejún MB, Colado A, Cordini G, Vergara-Rubio M, Podaza E, Risnik D, Cabrejo M, Fernández-Grecco H, Bezares RF, Custidiano MDR, Sánchez-Ávalos JC, Vicente Á, Garate GM, Borge M, Giordano M, Gamberale R. Elías EE, et al. Haematologica. 2018 Oct;103(10):e458-e461. doi: 10.3324/haematol.2018.188680. Epub 2018 May 10. Haematologica. 2018. PMID: 29748439 Free PMC article. No abstract available.
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Risnik D, Colado A, Podaza E, Almejún MB, Elías EE, Bezares RF, Fernández-Grecco H, Seija N, Oppezzo P, Borge M, Gamberale R, Giordano M. Risnik D, et al. Among authors: elias ee. Cancer Immunol Immunother. 2020 May;69(5):813-824. doi: 10.1007/s00262-020-02513-y. Epub 2020 Feb 13. Cancer Immunol Immunother. 2020. PMID: 32055920 Free PMC article.
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Elias EE, Sarapura Martinez VJ, Amondarain M, Colado A, Cordini G, Bezares RF, Fernandez Grecco H, Custidiano MDR, Sánchez Ávalos JC, Garate G, Pavlovsky MA, Borge M, Giordano M, Gamberale R. Elias EE, et al. Cancer Immunol Immunother. 2022 Apr;71(4):979-987. doi: 10.1007/s00262-021-03043-x. Epub 2021 Aug 31. Cancer Immunol Immunother. 2022. PMID: 34467417 Free PMC article.
19 results